Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+breast cancer"

被引：0
|
作者：
Cao, Lifen [1 ]
Stabellini, Nickolas [2 ]
Amin, Amanda L. [3 ]
Montero, Alberto J. [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Med Ctr,Dept Med,Div Hematol & Oncol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Med Ctr,Dept Surg,Div Surg Oncol, Cleveland, OH 44106 USA
来源：
CANCER | 2022年 / 128卷 / 16期
关键词：
D O I：
10.1002/cncr.34339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3130 / 3130
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF STAGE-I LUNG-CANCER (T1N0M0, T2N0M0)
    MOORES, DWO
    MCKNEALLY, MF
    SURGICAL CLINICS OF NORTH AMERICA, 1987, 67 (05) : 937 - 943
  • [22] PT1-T2 N0 M0 BREAST CANCER WITH EARLY RECCURENCE
    Zemni, I.
    Haddad, S.
    Adouni, O.
    Saadallah, F.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A62 - A63
  • [23] Stage I (T1N0M0) breast cancer (BC): Pathological characteristics and clinical outcome
    Basaran, Gul Atalay
    Cabuk, Devrim
    Caglar, Hale B.
    Iyikesici, Salih
    Tebessum, Cakir
    Gulluoglu, Bahadir
    Kaya, Handan
    Dane, Faysal
    Yumuk, Perran F.
    Turhal, Nazim S.
    ANNALS OF ONCOLOGY, 2006, 17 : 113 - 113
  • [24] Concomitant chemotherapy and radiotherapy in conservative treatment of breast cancer T1-2N0M0.
    Semiglazov, V
    Kanaev, S
    Bugrova, I
    Ivanov, V
    Barash, N
    Ivanova, O
    ANNALS OF ONCOLOGY, 2000, 11 : 20 - 21
  • [25] Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate
    Petrelli, Fausto
    Barni, Sandro
    MEDICAL ONCOLOGY, 2011, 28 (02) : 401 - 408
  • [26] Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate
    Fausto Petrelli
    Sandro Barni
    Medical Oncology, 2011, 28 : 401 - 408
  • [27] T1b with ER negative, HER2-positive, and node-negative breast cancer patients might get benefit from adjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (05): : 2529 - 2530
  • [28] Utilization of adjuvant trastuzumab for T1a,b N0 HER2+breast cancer in Ontario.
    Eisen, Andrea
    Yeung, Lyndee
    Gavura, Scott
    Brown, Zachary M.
    Trudeau, Maureen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] The comprehensive genomic profiling in early-stage (T1-2N0-1M0) breast cancer
    Chen, Bo
    Li, Yingzi
    Zhang, Yuchen
    Zhang, Guochun
    Du, Haiwei
    Sun, Dailin
    Li, Junjun
    Liao, Ning
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Adjuvant Chemotherapy Guidance in Young Breast Cancer Patients With Luminal Subtypes and Stage pT1N0
    Qiu, Juanjuan
    Du, Zhenggui
    Wang, Yao
    Zhou, Yuting
    Zhang, Junhui
    Liu, Pengcheng
    Lv, Qing
    JOURNAL OF SURGICAL RESEARCH, 2019, 240 : 165 - 174
12345